October 2, 2020
Physician's Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 28 to Oct. 2, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice. Primary Care Visits...
Primary Care Visits Dropped in Early Months of the Pandemic
FRIDAY, Oct. 2, 2020 (HealthDay News) — There has been a decrease in primary care office visits during the COVID-19 pandemic, according to a study published online Oct. 2 in JAMA Network Open. G. Caleb Alexander, M.D., from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues quantified national changes in the...
Exercise Lowers Mortality for Patients With Type 2 Diabetes
FRIDAY, Oct. 2, 2020 (HealthDay News) — Exercise cuts the risk for death in patients with type 2 diabetes, according to a study presented at the annual meeting of the European Association for the Study of Diabetes, held virtually from Sept. 21 to 25. Yun-Ju Lai, M.D., from the Taichung Veterans General Hospital in Taiwan,...
Ductal Carcinoma In Situ Tied to Threefold Higher Risk for Death
FRIDAY, Oct. 2, 2020 (HealthDay News) — There is a threefold higher risk for dying of breast cancer after a diagnosis of ductal carcinoma in situ (DCIS), according to a study published online Sept. 16 in JAMA Network Open. Vasily Giannakeas, M.P.H., from University of Toronto, and colleagues used the Surveillance, Epidemiology and End Results...
Older Adults Likely to Be Excluded From COVID-19 Trials
FRIDAY, Oct. 2, 2020 (HealthDay News) — Older adults are likely to be excluded from many COVID-19 clinical trials and all vaccine trials, according to a research letter published online Sept. 28 in JAMA Internal Medicine. Benjamin K.I. Helfand, from the University of Massachusetts Medical School in Worcester, and colleagues reviewed all COVID-19 treatment and...
Mortality Below 40 Percent for COVID-19 Patients Put on ECMO
FRIDAY, Oct. 2, 2020 (HealthDay News) — For patients with COVID-19 receiving extracorporeal membrane oxygenation (ECMO) support, mortality is below 40 percent, according to a study published online Sept. 25 in The Lancet. Ryan P. Barbaro, M.D., from the University of Michigan in Ann Arbor, and colleagues characterized epidemiology, hospital course, and outcomes for patients...
Considerable State-Level Variation Found in Prevalence of Eclampsia
FRIDAY, Oct. 2, 2020 (HealthDay News) — There is considerable state-level variation in the prevalence of eclampsia, according to a study published online Oct. 1 in JAMA Network Open. Alexander J. Butwick, M.B.B.S., from the Stanford University School of Medicine in California, and colleagues examined the extent of statewide variation in the prevalence of chronic...
Antibodies Decrease With Time After COVID-19 Symptom Onset
FRIDAY, Oct. 2, 2020 (HealthDay News) — Antibodies decrease with time after COVID-19 symptom onset, according to a research letter published online Oct. 1 in Blood. Josée Perreault, Ph.D., from Héma-Québec in Montréal, and colleagues analyzed severe acute respiratory syndrome coronavirus 2 spike protein receptor binding domain (RBD) antibody titers from potential COVID-19 convalescent plasma...
Outcomes Worse for Deferred Aortic Valve Replacement
FRIDAY, Oct. 2, 2020 (HealthDay News) — For patients with symptomatic severe aortic stenosis, deferred aortic valve replacement (AVR) is associated with an increased risk for hospitalization for valve-related symptoms or worsening heart failure, according to a research letter published online Sept. 30 in JAMA Network Open. Christoph Ryffel, M.D., from the Bern University Hospital...